Before using the first time, remove the protective cap from the tip and prime pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after use. • adults and children 6 to under1 2 years of age (with adult superv...
Oxymetazoline Hydrochloride 0.05% Nasal decongestant
Uses
• for the temporary relief of nasal congestion due to
the common cold, hay fever or other upper respiratory
allergies
• shrinks swollen membranes so you can breathe
more freely
Do not use this product if you have heart disease • high
blood pressure • thyroid disease
• diabetes • or difficulty in urination due to enlargement of
the prostate gland
•do not exceed recommended dosage • do not use for more than 3 days. Use only as directed. • may cause temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge • the use of this container by more than one person may spread infection • frequent or prolonged use may cause nasal congestion to recur or worsen
Keep out of reach of children. If product is swallowed, get medical help or contact a PoisonControl Center right away
Before using the first time, remove the protective cap from the tip and prime pump by depressing pump firmly several times.
To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after use. • adults and children 6 to under1 2 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 1 0 to 1 2 hours. Do not exceed 2 doses within any 24-hour period • children under 6 years of age: consult a doctor
Benzalkonium Chloride
Chlorhexidine Gluconate
Citric Acid
Disodium EDTA
Fragrance
Purified Water
Sodium Citrate
Sodium Hydroxide
Tyloxapol
| Class | Version | Type | Effective |
|---|---|---|---|
| OXYMETAZOLINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| e67be450-f8e4-4bc1-88bd-1259d379f55f | Product name | 1 | 20210127 |
| c53f3286-4062-4cf5-8355-399519c639a6 | Product name | 1 | 20170424 |
| a993dfc5-f219-4460-bde6-30dd724d9ef0 | Product name | 1 | 20160818 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0363-7000-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d55e-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-7000-01 | Nasal MistWalgreens | 15 mL in 1 BOTTLE | LIQUID | 15 | 3 | |
| 0363-7000-01 | Nasal MistWalgreens | 1 in 1 CARTON | LIQUID | 1 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-7000-01 | ML - Milliliter | 0363-7000 | 375fcaff-fba1-44b7-a3f2-8a797093199e | 1 | 2022-06-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0363-7000 | 0363-7000-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Oxymetazoline Hydrochloride | K89MJ0S5VY | ACTIB |
| Benzalkonium Chloride | F5UM2KM3W7 | IACT |
| Water | 059QF0KO0R | IACT |
| Chlorhexidine Gluconate | MOR84MUD8E | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| Sodium Citrate | 1Q73Q2JULR | IACT |
| Sodium Hydroxide | 55X04QC32I | IACT |
| Tyloxapol | Y27PUL9H56 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6bfd7191-45d1-4669-9795-f3a18d19d70d | 4140d017-72fd-4b8c-ab91-c7ae8e9e5f79 | 2018-06-14 | Warnings | 6bfd7191-45d1-4669-9795-f3a18d19d70d 4140d017-72fd-4b8c-ab91-c7ae8e9e5f79 |
Adverse event summaries are temporarily unavailable. Other product information remains available.